Intermediate for Rucaparib. Rucaparib (trade name Rubraca) is a PARP inhibitor targeting the DNA repair enzyme poly-ADP ribose polymerase-1 (PARP-1) for the treatemnt of advanced ovarian cancer. Rucaparib has been approved by the U.S Food and Drug Administration on December 19, 2016.
Specifications
Product Name: Methyl 5-fluoro-2-methyl-3-nitrobenzoate
Synonyms: N/A
CAS Number: 697739-03-0
Molecular Weight:  213.1649
Molecular Formula:  C9H8FNO4
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.
SMILES: COC(=O)c1cc(F)cc(c1C)[N+](=O)[O-]